TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bristol-Myers Squibb Norway AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
985,253
|
133,185
|
111,253 |
| Financial expenses |
2,962
|
247
|
350 |
| Earnings before taxes |
41,938
|
6,557
|
5,635 |
| Total assets |
404,572
|
177,728
|
177,813 |
| Current assets |
404,257
|
177,500
|
177,708 |
| Current liabilities |
171,528
|
39,374
|
36,527 |
| Equity capital |
233,045
|
138,354
|
141,286 |
| - share capital |
630
|
663
|
565 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.6%
|
77.8%
|
79.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.3%
|
4.9%
|
5.1% |
| Return on assets (ROA) |
11.1%
|
3.8%
|
3.4% |
| Current ratio |
235.7%
|
450.8%
|
486.5% |
| Return on equity (ROE) |
18.0%
|
4.7%
|
4.0% |
| Change turnover |
858,755
|
28,768
|
-246,952 |
| Change turnover % |
679%
|
28%
|
-69% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.